Chun-hui Lee
Tainan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR-Mutant Non-Small Cell Lung Cancer: A Case Series.
Journal: Current oncology (Toronto, Ont.)
Published: April 13, 2026
Dynamic 3D imaging system detects vasculogenic mimicry and screens inhibitors in EGFR-mutant lung cancer.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: March 04, 2026
Trastuzumab Deruxtecan in Patients With HER2-Overexpressing NSCLC: Results From Part 1 of the Open-Label, Multicenter, Phase 1b DESTINY-Lung03 Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 03, 2025
Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase Inhibitors.
Journal: Clinical lung cancer
Published: April 10, 2025
A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 24, 2024
NUPR1 contributes to endocrine therapy resistance by modulating BIRC5 expression and inducing luminal B-ERBB2+ subtype-like characteristics in estrogen receptor-positive breast cancer cells.
Journal: Journal of Cancer
Published: October 18, 2024
Allogeneic hematopoietic stem cell transplantation for B-cell lymphoma in Taiwan.
Journal: Cancer medicine
Published: August 07, 2023
Long-term use of denosumab and its association with skeletal-related events and osteonecrosis of the jaw.
Journal: Scientific reports
Published: December 13, 2022
Application of PLASMIC Score in Risk Prediction of Thrombotic Thrombocytopenic Purpura: Real-World Experience From a Tertiary Medical Center in Taiwan.
Journal: Frontiers in medicine
Published: March 10, 2022
PI3K inhibitors in trastuzumab-resistant HER2-positive breast cancer cells with PI3K pathway alterations.
Journal: American journal of cancer research
Published: March 08, 2022
Subtle cardiac dysfunction in lymphoma patients receiving low to moderate dose chemotherapy.
Journal: Scientific reports
Published: July 15, 2020
Comprehensive assessment of HER2 alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significance.
Journal: Cancer management and research
Published: April 24, 2019
Last Updated: 09/26/2026